Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L)’s 10x Genomics TXG Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TXG Stock Details TXG Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.71M	Buy
2023 Q1	–	Sell
2022 Q4	$914K	Buy